As of 2026-09-30, the EV/EBITDA ratio of bluebird bio Inc (BLUE) is -1.11. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLUE's latest enterprise value is 129.30 mil USD. BLUE's TTM EBITDA according to its financial statements is -116.20 mil USD. Dividing these 2 quantities gives us the above BLUE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.9x - 17.7x | 16.4x |
| Forward P/E multiples | 18.8x - 23.5x | 20.9x |
| Fair Price | (231.86) - (218.33) | (229.31) |
| Upside | -4765.3% - -4493.0% | -4713.9% |
| Date | EV/EBITDA |